# Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis

> **NCT05672472** · NA · UNKNOWN · sponsor: **The First Hospital of Jilin University** · enrollment: 100 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Sivelestat sodium

## Key facts

- **NCT ID:** NCT05672472
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-10
- **Primary completion:** 2025-01-10
- **Final completion:** 2025-02-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05672472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05672472, "Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05672472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*